IRDye 800CW 2-DG (2-deoxyglucose) is a fluorescent optical imaging agent shown to be reactive with implanted tumors derived from many cell lines including A431, SW620, 3T3-L1, and PC3LMN4.

IRDye 800CW Optical Probe is used for studies involving bone metastasis and remodeling.

IRDye 800CW RGD Optical Probe is a near-infrared fluorescently labeled RGD imaging agent used to target the overexpression of integrins on tumors.

IRDye 680RD BoneTag Optical Probe is a calcium-chelating compound conjugated to IRDye 680RD near-infrared dye for use as a marker of the mineralization process.

IRDye 800CW PEG Contrast Agent (25-60 kDa) is a non-specific imaging agent intended to exploit enhanced permeability and retention (EPR) in tumor biology.